SBRT for Oligoprogression Improves Outcomes in NSCLC but Not Breast Cancer
Treating oligoprogression with SBRT improved progression-free survival in patients with lung cancer but not in those with breast cancer.
Diagnosis & Disease Information
Long-Term Data Support HFRT as Standard Care in High-Risk Prostate Cancer
Hypofractionated radiotherapy produces similar long-term outcomes as conventionally fractionated radiotherapy in high-risk prostate cancer, a phase 3 study suggests.
Radiotherapy of Asymptomatic Bone Metastases Reduces Skeletal-Related Events
Prophylactic radiotherapy of asymptomatic bone metastases can reduce skeletal-related events and improve survival in patients with solid tumors, a study suggests.
Durvalumab Plus IMRT No Better Than Cetuximab Plus IMRT in Head and Neck Cancer
Durvalumab plus IMRT proved no more effective than cetuximab plus IMRT in patients with treatment-naïve, locoregionally advanced head and neck squamous cell carcinoma.
SBRT Proposed as Standard Treatment Option for Advanced Hepatocellular Carcinoma
Adding stereotactic body radiation therapy to sorafenib improves survival outcomes in patients with advanced hepatocellular carcinoma, a phase 3 trial suggests.
Concurrent Radiation Boost Comparable to Sequential Boost in High-Risk Breast Cancer
A concurrent radiation boost produces comparable outcomes as a sequential boost in patients with high-risk breast cancer, a phase 3 study suggests.
Predicting the Risk of Thoracic Soft Tissue Sarcoma After Breast Cancer
There are several factors that may increase the risk of thoracic soft tissue sarcoma in patients with a history of breast cancer.
S-1-Based Chemoradiotherapy Improves Outcomes in Elderly Patients With Esophageal Squamous Cell Carcinoma
Adding oral S-1 chemotherapy to radiotherapy can improve outcomes in elderly patients with inoperable esophageal squamous cell carcinoma.
Mepitel Film Reduces Radiation Dermatitis in Breast Cancer Patients
Mepitel Film reduced the rate of grade 2-3 radiation dermatitis in patients with breast cancer.
Pediatric Cancer Patients Treated With RT May Have Increased Risk of Meningioma for 30 Years
Patients who undergo radiotherapy for the treatment of childhood cancer have an increased risk of developing meningioma later in life, and that risk may persist for 30 years.
- Loading...
Loading...
Next post in Pediatric Cancer
Loading... 
Loading...